JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jensen, T. J.
Right arrow Articles by Nedergaard, O. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jensen, T. J.
Right arrow Articles by Nedergaard, O. A.

Vol. 291, Issue 1, 7-11, October 1999

Modulation of Norepinephrine Release from Sympathetic Neurons of the Rabbit Aorta by Prejunctional Prostanoid Receptors1

Tenna Juul Jensen and Ove A. Nedergaard

Department of Pharmacology, School of Medicine, Odense University, Odense, Denmark

The pharmacological properties and subtypes of prostanoid receptors involved in the prejunctional modulation of [3H]norepinephrine release from sympathetic neurons were studied using isolated rabbit aorta. Rings preincubated with [3H]norepinephrine were washed with physiological salt solution that contained cocaine plus corticosterone, uptake1 and uptake2 inhibitors, respectively, and rauwolscine to block prejunctional alpha 2-adrenoceptors. Electrical field stimulation was used to evoke 3H overflow. Prostaglandin (PG)E2 (10-9 to 3 × 10-7 M) reduced the stimulation-evoked 3H overflow; the pEC50 value was 8.3, and Emax value was 98%. This effect was also seen with PGE1, PGD2, PGF2alpha , the EP1/EP3 receptor agonist sulprostone, the EP2/EP3 receptor agonist misoprostol, and the EP1/IP receptor agonist iloprost; the rank order (pEC50) was sulprostone (8.4) > PGE2 (8.3) > misoprostol (8.1) > PGE1 (7.9) > PGF2alpha (6.0) > PGD2 (<5.0). This rank order suggests that these agents act on prejunctional prostaglandin receptors of the EP3 subtype. The stable thromboxane A2 analog U46619 (9,11-dideoxy-11alpha , 9alpha -epoxymethano-PGF2alpha ) slightly reduced the stimulation-evoked 3H overflow. The FP receptor agonist fluprostenol and the EP2 receptor agonist butaprost had no effect. The EP receptor antagonist AH6809 (6-isopropoxy-9-oxoxanthene-2-carboxylic acid) did not alter the inhibitory effect of PGE2 and sulprostone. AH6809 did not modulate the stimulation-evoked 3H overflow. This suggests that prejunctional EP1 receptors are not involved. The IP receptor agonist cicaprost reduced the 3H overflow only at concentrations higher than 3 × 10-5 M. We conclude that the postganglionic sympathetic neurons in rabbit aorta are endowed with prejunctional inhibitory EP3 receptors. FP and IP receptors are not present, and the possible presence of inhibitory DP receptors requires further study.


0022-3565/99/2911-0007$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
L. E. Rasmussen and O. A. Nedergaard
Effects of Reboxetine on Sympathetic Neuroeffector Transmission in Rabbit Carotid Artery
J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 995 - 1002.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. Boehm and H. Kubista
Fine Tuning of Sympathetic Transmitter Release via Ionotropic and Metabotropic Presynaptic Receptors
Pharmacol. Rev., March 1, 2002; 54(1): 43 - 99.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.